Literature DB >> 3298560

Etiology and treatment of chemotherapeutic agent extravasation injuries: a review.

R Rudolph, D L Larson.   

Abstract

While extravasation from intravenous (IV) lines is common and usually benign, leakage of certain drugs can cause severe skin ulceration. These ulcerogenic drugs can be conveniently divided into two categories, depending on whether they bind to DNA. Chemotherapeutic agents such as doxorubicin, which bind to DNA, are especially prone to cause severe extravasation skin ulcers. These ulcers are often chronic and progressive. Neither clinical nor experimental studies have shown an antidote to doxorubicin extravasation, which is best prevented by careful technique. If extravasation is suspected, the infusion should be immediately stopped. In the event of extravasation, elevation and ice are the currently recommended treatment. While small ulcerations may on occasion heal, large ulcerations require surgical excision for relief of pain and salvage of underlying tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298560     DOI: 10.1200/JCO.1987.5.7.1116

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  17 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 2.  [Prevention, early diagnosis and treatment of chemoextravasation. Practical management in the uro-oncological practice].

Authors:  L Rinnab; M Ringhoffer; R Mayer-Steinacker; R E Hautmann; J Simon
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

3.  Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

Authors:  C R Thomas; K J Stelzer; J G Douglas; W J Koh; L V Wood; R Panicker
Journal:  J Natl Med Assoc       Date:  1994-11       Impact factor: 1.798

Review 4.  Clinical pharmacokinetics of doxorubicin.

Authors:  P A Speth; Q G van Hoesel; C Haanen
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

5.  Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.

Authors:  H J Lawrence; D Walsh; K A Zapotowski; A Denham; S H Goodnight; D R Gandara
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 6.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 7.  [Extravasation of cytotoxic agents].

Authors:  Elisabeth Nogler-Semenitz; Ines Mader; Patrizia Fürst-Weger; Robert Terkola; Sabine Wassertheurer; Pietro Giovanoli; Robert M Mader
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704

Review 8.  Administration of chemotherapeutic agents. Techniques and controversies.

Authors:  J H Raaf
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

9.  Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig.

Authors:  H Hajarizadeh; L Lebredo; R Barrie; E A Woltering
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

10.  Extravasational side effects of cytotoxic drugs: A preventable catastrophe.

Authors:  Jagdeep S Thakur; C G S Chauhan; Vijay K Diwana; Dayal C Chauhan; Anamika Thakur
Journal:  Indian J Plast Surg       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.